Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Using credit cards for cash advances can be a quick solution in a pinch. Understand the pros and cons before making a decision.
20,713 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
A Tuesday rally put Tower Semiconductor in the spotlight as investors priced in capacity upgrades and stronger demand...
Arm Holdings faces a cooling pullback after a strong rally, offering a potential entry point for long-term investors....
Bitcoin’s spot market remains in a cautious lull even as futures and options activity picks up. Analysts say the shif...
Tori Spelling says her California rental, home to five children, costs $12,000 a month and feels chaotic. The remark ...
When Apple moves more of its production to the U.S., investors often respond quickly. This article explains why apple...
Intuitive Machines announced an $800 million acquisition that pivots the company from lunar landers to a full space p...
A sharp February move put Remitly Global in the spotlight. This article breaks down the catalysts behind the rally, t...
A director sold 2,700 Wingstop shares, sparking questions about the stock's outlook. This guide breaks down what insi...
Rivian’s April milestone could reshape its growth path. This article breaks down why April could huge for Rivian, wha...
Northrop Grumman has surged in 2026 on a record backlog and strong cash flow, but a major program in limbo keeps inve...
When oil surges, mining companies feel the sting long before metals move. This article breaks down how energy costs p...